Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1

Interventions

Specimen Handling 69Magnetic Resonance Spectroscopy 52Biopsy 42pembrolizumab 26Carboplatin 26Cyclophosphamide 25Radiation 24Radiotherapy 23Nivolumab 23Cisplatin 21Paclitaxel 20olaparib 18Etoposide 18Doxorubicin 18Vincristine 17Dexamethasone 17X-Rays 16Immunoglobulin G 15Disulfides 15Cytarabine 15Taxes 14Prednisone 14Platinum 14Leucovorin 14Bevacizumab 141,2-diaminocyclohexaneplatinum II citrate 14durvalumab 13Radiotherapy, Intensity-Modulated 12Ipilimumab 12atezolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Mastectomy, Segmental × 30 days × Clear all
NCT02927912 2026-06-03

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
108 enrolled 8 charts
Breast

Breast Neoplasms

NCT02883062 2026-05-28

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
67 enrolled 16 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡